Dermatologists use novel combination therapy to restore skin color in vitiligo patients
Doctors and dermatologists alike have searched for an effective treatment option for vitiligo. A recent study conducted by a team of Yale doctors may have found just that. Utilizing an off-label use of the arthritis medication, tofacitinib, and narrow band ultraviolet B light therapy has resulted in promising and positive patient outcomes. By experimenting with this combination of therapies in recent studies, patients have noticed total or close to total restoration of skin color in affected areas. There is still much to learn about this revolutionary treatment option; however, what is known so far is assuring.